Biznextindia : Zydus Cadila has introduced a new feature in the packaging of its critical drugs to help patients ensure that the product is not fake or counterfeited. The company has incorporated a new IT enabled scratch code which shall be printed under a scratchable surface. The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website.
This security feature developed by Hyperlink Infosystem enables patients and institutions detect counterfeits. Buyers need to scratch the code and immediately verify this on an app or website. To start with the technology is being implemented in the Company’s products Remdac (Remdesivir) and Virafin Inj (Pegylated Interpheron Alpha 2b) and will be seen on the product packs in the third week of June. The new feature will also be extended to other products of the company.
“The problem of counterfeit drugs undermines the painstaking efforts that are put in to ensure that the end user or patients receive a product that is safe and manufactured with the highest standards of quality excellence. Counterfeit drugs can be harmful as they may not have the desired outcome and could also be life threatening in some cases. To curb this menace we looked at a user friendly solution which can reassure the patient that the product is genuine and safe. Zydus Verify is a techenabled solution that will safeguard patients against counterfeit drugs” Dr. Sharvil Patel, Managing Director, Cadila Healthcare Ltd., said.